Stock Taper Q4 Revenue: $225.3 million, a 4.3% increase on a core basis, marking the highest growth rate of the fiscal year.
Food Safety Revenue: $166.8 million, with core growth of 5.8%, driven by strong performance in indicator testing and culture media products.
Animal Safety Revenue: Grew 0.5% year-over-year, with a 7% sequential increase.
Gross Margin: 47.8%, with an adjusted gross margin of 49.7%, up 330 basis points year-over-year.
Adjusted EBITDA: $45.4 million, representing a margin of 20.2%, up 12% year-over-year.
Cash Flow: Over $30 million in cash flow from operations, with free cash flow exceeding $26 million.
Debt: Approximately $794 million in gross debt, with a cash balance of $185.5 million.
Core Growth: Notable recovery in both Food Safety and Animal Safety segments, with Food Safety achieving its highest growth since 2023.
Strategic Initiatives: Focus on commercial prowess, high-impact innovation, and operational efficiency.
Commercial Strategy: Transitioning to a solutions-based sales model and enhancing customer engagement through strategic account management.
Innovation Investment: R&D spending to increase by 50%, targeting a long-term goal of 5% of revenue.
Petrifilm Manufacturing Transition: On track for a multi-quarter transition starting November 2026, with the first SKU validation expected in August.
Operational Improvements: Significant reductions in inventory levels and improved on-time delivery metrics.
Fiscal Year 2027 Guidance: Expected revenue of $880 million to $885 million, with adjusted EBITDA of $180 million to $182 million, implying core growth of approximately 3%.
Q1 FY27 Guidance: Revenue projected at $207 million to $209 million, with adjusted EBITDA around $37 million.
Long-term Goals: Aiming for approximately 30% adjusted EBITDA margins through disciplined cost management and strategic investments.
Macroeconomic Headwinds: Customers facing inflationary pressures due to geopolitical factors, which may temper growth despite positive industry trends.
Currency Impact: Anticipated negative 1% impact from currency fluctuations in FY27.
Competitive Landscape: While Neogen aims to lead, there is acknowledgment of needing to catch up in certain areas, particularly in e-commerce capabilities.
Investment Impact on Margins: Increased investments in R&D and operational initiatives may pressure margins in the short term.
EBITDA Guidance Clarification: Concerns were raised regarding the EBITDA guidance being below expectations. Management explained that additional investments would limit margin expansion in FY27.
Core Growth Split: Management did not provide specific growth rates for Food Safety versus Animal Safety but indicated that Food Safety is expected to grow faster.
Strategic Focus: Emphasis on transitioning to a solutions-based approach and engaging with strategic accounts at higher organizational levels to drive growth.
Innovation Timeline: Acknowledgment that the innovation cycle requires early investment to realize future product launches, with a focus on addressing customer needs through differentiated technologies. Overall, Neogen is positioned for growth with a focus on innovation and operational efficiency, despite facing macroeconomic challenges and competitive pressures.
SOURCE: Q4 2026 EARNINGS CALL TRANSCRIPT